Disclosed is a method and composition for nutritional compositions containing glucosidase inhibitors, and more specifically Touchi Extract and its uses in the treatment of many disorders. These disorders include diabetes, hyperlipidemia, obesity, Metabolic syndrome/Syndrome X, COPD, malabsorption, Crohn's disease, diarrhea, constipation, irritable bowel syndrome, human immunodeficiency virus, cystic fibrosis, non-alcoholic steatohepatitis, polycystic ovarian syndrome including associate infertility, and erectile dysfunction. Further, glucosidase inhibitors, and more specifically Touchi Extract can be used to aid healing in critical care patients and for general wound healing. Additionally, glucosidase inhibitors, including Touchi Extract can be used to enhance athletic performance.

Falk; Anne

Roughead; Zamzam (Fariba)

Miller; Kevin Burke

Jonnalagadda; Satya

Greenberg; Norman Alan

Kaspar; Kala Marie

Swanson; Julie

Nestec S.A.

Methods of use and nutritional compositions of Touchi Extract

The present inventions relates to the use of certain benzimidazole compounds in the treatment of diseases caused by microsporidia organisms, in particular the treatment of diarrhea in patients infected with human immunodeficiency virus.

primary immunodeficiency diseases/diarree

Methods of use and nutritional compositions of Touchi Extract

Benzimidazole anthelmintic in the treatment of microsporidial infections

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap